6-Aziridin-1-yl-7-methyl-1,4-dihydro-2H-cyclopenta[b]indole-3,5,8-trione

ID: ALA143527

PubChem CID: 10445119

Max Phase: Preclinical

Molecular Formula: C14H12N2O3

Molecular Weight: 256.26

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1=C(N2CC2)C(=O)c2[nH]c3c(c2C1=O)CCC3=O

Standard InChI:  InChI=1S/C14H12N2O3/c1-6-12(16-4-5-16)14(19)11-9(13(6)18)7-2-3-8(17)10(7)15-11/h15H,2-5H2,1H3

Standard InChI Key:  JSNMHIJIQZVMGI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    6.1875   -6.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1875   -6.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7542   -5.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1500   -6.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6625   -7.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1500   -6.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6625   -5.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1042   -6.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7542   -6.9000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6292   -7.0125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0292   -7.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3292   -7.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6750   -6.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1125   -5.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6625   -7.6125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6625   -5.2125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6792   -5.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1875   -6.5250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6292   -5.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  6  2  0
  5  2  1  0
  6  7  1  0
  7  1  1  0
  8  3  2  0
  9  2  1  0
 10  4  1  0
 11 10  1  0
 12 10  1  0
 13  8  1  0
 14  3  1  0
 15  5  2  0
 16  7  2  0
 17 14  1  0
 18 13  2  0
 19  6  1  0
  8  9  1  0
  4  5  1  0
 17 13  1  0
 11 12  1  0
M  END

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prostatic carcinoma cell (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 256.26Molecular Weight (Monoisotopic): 256.0848AlogP: 1.11#Rotatable Bonds: 1
Polar Surface Area: 70.01Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.16CX Basic pKa: CX LogP: 0.16CX LogD: -0.19
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.76Np Likeness Score: 0.66

References

1. Xing C, Wu P, Skibo EB, Dorr RT..  (2000)  Design of cancer-specific antitumor agents based on aziridinylcyclopent[b]indoloquinones.,  43  (3): [PMID:10669573] [10.1021/jm990466w]

Source